2012
DOI: 10.1016/j.jacl.2011.08.009
|View full text |Cite
|
Sign up to set email alerts
|

Reduced cellular cholesterol efflux and low plasma high-density lipoprotein cholesterol in a patient with type B Niemann-Pick disease because of a novel SMPD-1 mutation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 34 publications
0
6
0
Order By: Relevance
“…Ceramide is a molecule with pro-apoptotic and anti-proliferative properties, and recent reviews examine the role of ceramide as an anti-cancer molecule [24], [25] and the association of elevated glucosylceramide with Gaucher-associated malignancies [26]. Similar links between low ceramide and colon cancer have also been suggested in the setting of Niemann-Pick type B disease [22]. Chemotherapeutic agents which increase ceramide levels promote cell death of cancer cells [27], and conversely, altered sphingolipid metabolism in cancer cells lead to carcinogenesis, cancer progress and chemotherapeutic resistance [27].…”
Section: Discussionmentioning
confidence: 92%
See 1 more Smart Citation
“…Ceramide is a molecule with pro-apoptotic and anti-proliferative properties, and recent reviews examine the role of ceramide as an anti-cancer molecule [24], [25] and the association of elevated glucosylceramide with Gaucher-associated malignancies [26]. Similar links between low ceramide and colon cancer have also been suggested in the setting of Niemann-Pick type B disease [22]. Chemotherapeutic agents which increase ceramide levels promote cell death of cancer cells [27], and conversely, altered sphingolipid metabolism in cancer cells lead to carcinogenesis, cancer progress and chemotherapeutic resistance [27].…”
Section: Discussionmentioning
confidence: 92%
“…A review of the literature on Gaucher disease and associated malignancies has reported several cases of hepatocellular carcinoma, colon cancer, breast cancer and other tumor pathologies [21]. Colon cancer and hepatocellular carcinoma have also been reported in Niemann-Pick type B patients [22], [23].…”
Section: Discussionmentioning
confidence: 99%
“…A defect in SMPD1 causes Niemann-Pick disease, 54 one phenotype of which is lipid abnormality including low HDL levels as a result of increased sphingomyelin content. 55,56 Recently, compound heterozygosity (rs120074118 [p.Arg610del] and rs120074127 [p.Ar-g443Ter]) 57 and a novel SNP (c.1480G>T [p.G494C]) 58 at SMPD1 have been shown to be strongly associated with low HDL levels in patients with Niemann-Pick disease. As PON1 SNP rs854560 also affects HDL levels, 59 rs854560 could be associated with SNPs of the SMPD family, in relation not only to HDL levels but also to the pathogenesis of periodontitis.…”
Section: Discussionmentioning
confidence: 99%
“…These patients have been reported to have a severe reduction in plasma HDL cholesterol [159161] and SM-enriched HDL [162]. This abnormal HDL composition may cause a decrease in LCAT activity and a lack of HDL maturation [163,164], and was a consequence of a reduced cholesterol efflux [165]. In Tangier disease, the relative quantity of long-chain fatty acids (23 or more carbons) in serum SM was about 38% lower than that of control sera [166].…”
Section: Factors Influencing Hdl-smmentioning
confidence: 99%